Note: These are based on policies enacted after the COVID-19 public health emergency was declared in January 2020 and are subject to change.
1. On Jan. 1, CMS will stop handing out $40 reimbursements for every COVID-19 vaccine administered by pharmacists. The payment will align with the rate set by other Part B vaccines. Free vaccine jabs for the public will also end. Moderna and Pfizer have tentatively said they plan to sell their shots for up to $130 each.
2. COVID-19 treatments such as Paxlovid will no longer be free for patients at the end of PHE.
3. CMS will stop covering up to eight COVID-19 at-home tests.
4. States and private insurance companies have the option to continue covering pharmacist-provided services, including COVID-19 testing, but there will no longer be a federal requirement to do so.
5. During the PHE, clinicians registered with the Drug Enforcement Administration have been able to prescribe schedule II-V controlled substances to patients they have not seen in person but with whom they have done a telehealth visit. This will expire.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.